Central nervous system (CNS) gene DNA loci (CNS DNA loci)

Central nervous system (CNS) gene DNA loci refer to the specific physical locations on chromosomes that harbor genes and regulatory elements essential for the development and physiological function of the brain and spinal cord (National Institutes of Health, 2023). These loci include protein-coding sequences that define neuroreceptors and enzymes, as well as non-coding regions like enhancers and promoters that orchestrate complex neural processes (Nature Reviews Neuroscience, 2022). Mutations, deletions, or epigenetic alterations within these genomic regions are fundamental to the pathogenesis of various neurological and psychiatric conditions, such as Alzheimer's disease, Huntington's disease, and spinal muscular atrophy (PubMed, 2023). While "CNS gene DNA loci" is a broad genomic category rather than a single therapeutic target, specific loci within this group are the focus of advanced precision medicines, including gene replacement therapies and antisense oligonucleotides (ASOs) (NIH, 2024). For example, the drug onasemnogene abeparvovec is designed to deliver a functional copy of the SMN1 gene to its corresponding locus to treat spinal muscular atrophy. Understanding the spatial and functional organization of these loci is critical for identifying novel biomarkers and developing site-specific genetic interventions for CNS disorders.

Other names

CNS genomic regionsNeural gene lociNeurogenetic lociCNS conserved non-coding sequences

Modulation of gene expression or sequence through gene therapy, antisense oligonucleotides, or gene editing at specific neural genomic sites.